Navigation Links
New dosage of medicine gets more results in neuroblastoma

In the second phase of study that is trying new approaches to the neuroblastoma patients, researchers// say that improved dosage of the drug topotecancan be more effective in children than the common procedure.

Scientists at St. Jude Children's Research Hospital, US, feel that the cancer drug topotecancan must be fine tuned to suit each child patient of neuroblastoma as not all doses are effective on everybody. Only less than half the children treated for neuroblastoma with the drug topotecancan are able to survive in the long run. That is why it is important to monitor and adjust the drug levels, in a process called pharmacokinetic-based (PK-based) dosing, to get the maximum benefit out of the drug.

The researchers have found that the PK-based dosages improve the chance of survival by prolonging the child’s cancer to the drug. Often reducing the size of the cancer tumor with the drug means that it will be easier to remove the malignant growth in the surgery. 40% of the patients enrolled for the study were surviving when the article was written. The study was published in the current issue of Clinical Oncology.

Reference: Clinical Oncology, June 2005
'"/>




Page: 1

Related medicine news :

1. Alternative medicine more popular among HIV positive patients
2. Complementary and Alternative medicine
3. Pharmacies in for a dose of bitter medicine
4. Magnetic resonance angiography in clinical medicine
5. Approaching through Telemedicine benefits patients
6. Spreading knowledge to doctors about herbal medicine
7. Diuretics are better for treating blood pressure problems than newer medicines
8. New medicine for ovarian cancer
9. Delay medicine for early epilepsy, says scientists
10. Folk medicine is given more to UTI patients
11. Prohibited diet medicine found in Chinese herbs
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/28/2017)... ... March 29, 2017 , ... ... pharmacist Dr. Isabella Wentz, Pharm.D., FASCP. The program was recently launched on March ... common questions regarding thyroid function. , Dr. Izabella Wentz is a licensed ...
(Date:3/28/2017)... NY (PRWEB) , ... March 28, 2017 , ... ... process management software and services, is proud to announce it has joined the ... professional association representing the interests of chronically ill, disabled, and dying Americans of ...
(Date:3/28/2017)... ... March 28, 2017 , ... Alert Sentry Group LLC., a leader in the ... Systems), the iSAFE and the iSAFE Plus. These iSAFE products are the most affordable ... the iSAFE and iSAFE Plus offer direct GPS Location and two-way calling with the ...
(Date:3/28/2017)... ... 28, 2017 , ... Usually, the impending arrival of warmer weather means the ... about a double chin, this means more anxiety than elation. The cosmetic dermatology experts ... people, a double chin is undesirable,” Dr. Goldman said, “but it seems doubly so ...
(Date:3/28/2017)... (PRWEB) , ... March 28, 2017 , ... ... leading physicians, Paul Yost, will begin serving as new board chair for Orange ... month. Yost will serve the remainder of soon-to-be former chair Mark Refowitz’s term, ...
Breaking Medicine News(10 mins):
(Date:3/28/2017)... TORONTO , March 28, 2017 /PRNewswire/ - StarFish ... medical device development firm, announced today that it has ... -based medical device industrial design and productization organization.  ... throughout North America with easier ... talent spanning the design, engineering, regulatory, and manufacturing process. ...
(Date:3/28/2017)... March 28, 2017  Akcea Therapeutics, a subsidiary of Ionis ... company,s board of directors: ... Gabrieli will serve as chairman of the board of Akcea ... commercial officer of Forest Laboratories. Sandford ... "We are excited to announce this ...
(Date:3/28/2017)... , March 28, 2017 ... to reach USD 8.0 billion by 2025, according to ... increasing incidence of infectious diseases and cancer is expected ... in disease diagnosis over the coming years. In addition, ... of autologous and allogenic stem cell therapy, due to ...
Breaking Medicine Technology: